Establishment and characterization of a new highly metastatic human osteosarcoma cell line

[1]  T. He,et al.  S100A6 Expression and Function in Human Osteosarcoma , 2008, Clinical orthopaedics and related research.

[2]  T. He,et al.  Osteosarcoma Development and Stem Cell Differentiation , 2008, Clinical orthopaedics and related research.

[3]  E. Lengyel,et al.  Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface* , 2008, Journal of Biological Chemistry.

[4]  Young-Chae Chang,et al.  Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. , 2007, Journal of biochemistry and molecular biology.

[5]  M. Kurosaka,et al.  High Level of Ezrin mRNA Expression in an Osteosarcoma Biopsy Sample With Lung Metastasis , 2007, Journal of pediatric hematology/oncology.

[6]  D. Jeon,et al.  Ezrin Expression Predicts Survival in Stage IIB Osteosarcomas , 2007, Clinical orthopaedics and related research.

[7]  W. Li,et al.  [Establishment of orthotopic model of MG-63 osteosarcoma]. , 2007, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[8]  Dafydd G. Thomas,et al.  Ezrin mediates growth and survival in Ewing’s sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway , 2006, Clinical & Experimental Metastasis.

[9]  F. Bertoni,et al.  Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. , 2006, Pathology, research and practice.

[10]  P. Steeg.  Cancer biology: Emissaries set up new sites , 2005, Nature.

[11]  M. Gebhardt,et al.  Survival Data for 648 Patients with Osteosarcoma Treated at One Institution , 2004, Clinical orthopaedics and related research.

[12]  J. Ioannidis,et al.  Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma , 2004, Clinical Cancer Research.

[13]  H. Kang,et al.  Imaging findings of extrapulmonary metastases of osteosarcoma. , 2004, Clinical imaging.

[14]  K. Hunter.  Ezrin, a key component in tumor metastasis. , 2004, Trends in molecular medicine.

[15]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[16]  P. Picci,et al.  Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcomaFindings in 42 patients followed for 1–16 years , 2004, Acta orthopaedica Scandinavica.

[17]  A. Heimberger,et al.  A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  N. Jaffe,et al.  Single and multiple metachronous osteosarcoma tumors after therapy , 2003, Cancer.

[19]  P. Meltzer,et al.  Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  A. Sandberg,et al.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. , 2003, Cancer genetics and cytogenetics.

[21]  W. Winkelmann,et al.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Mansel,et al.  The role of the CD44/ezrin complex in cancer metastasis. , 2003, Critical reviews in oncology/hematology.

[23]  E. Fearon,et al.  Cadherin and catenin alterations in human cancer , 2002, Genes, chromosomes & cancer.

[24]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  P. Meltzer,et al.  Metastasis-associated differences in gene expression in a murine model of osteosarcoma. , 2001, Cancer research.

[26]  A. Craft,et al.  Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.

[27]  M. Stevens,et al.  Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.

[28]  C. Rinker-Schaeffer,et al.  Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.

[29]  S. Kaste,et al.  Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis , 1999, Cancer.

[30]  H. Kimura,et al.  Prognosis of Osteosarcoma With Pulmonary Metastases at Initial Presentation Is Not Dismal , 1998, Clinical orthopaedics and related research.

[31]  M. Robbin,et al.  The many faces of osteosarcoma. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[32]  P. Terrier,et al.  Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  E. Holmes,et al.  Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Barrett,et al.  A gene involved in control of human cellular senescence on human chromosome 1q , 1994, Molecular and cellular biology.

[35]  W. Akeson,et al.  Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. , 1993, Cancer research.

[36]  D. Haines,et al.  Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1. , 1992, Anticancer research.

[37]  I. Elomaa,et al.  The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  G. Laurent,et al.  * Author for correspondence Summary , 2022 .

[39]  J. Shuster,et al.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. , 1986, The New England journal of medicine.

[40]  A. Hart,et al.  Some prognostic and epidemiologic factors in canine osteosarcoma. , 1979, Journal of the National Cancer Institute.

[41]  J. Rhim,et al.  Characterization of human cells transformed in vitro by n‐methyl‐n'‐nitro‐n‐nitrosoguanidine , 1977, International journal of cancer.

[42]  A. Montag,et al.  An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis , 2005, Clinical & Experimental Metastasis.

[43]  H. Schuller,et al.  Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma , 2005, Journal of Cancer Research and Clinical Oncology.

[44]  L. Helman,et al.  An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential , 2004, Clinical & Experimental Metastasis.

[45]  T. Böhling,et al.  Chemotherapy in osteosarcomaThe Scandinavian Sarcoma Group experience , 1999, Acta orthopaedica Scandinavica. Supplementum.

[46]  A. Skubitz.  Adhesion molecules. , 2002, Cancer treatment and research.

[47]  R. Schneider-Stock,et al.  Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors. , 1998, Pathology, Research and Practice.

[48]  A. Billiau,et al.  In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. , 1978, Oncology.

[49]  A. Billiau,et al.  In vitro cultivation of human tumor tissues. , 1975, Oncology.